Table of Contents
ISRN Hepatology
Volume 2013 (2013), Article ID 206875, 9 pages
http://dx.doi.org/10.1155/2013/206875
Research Article

Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer

1Division of Surgical Oncology, Department of Surgery, MSC 07 4025, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131-0001, USA
2Eppley Cancer Center, University of Nebraska Medical Center, 985950 Nebraska Medical Center, Omaha, NE 68198-5950, USA

Received 22 January 2013; Accepted 17 March 2013

Academic Editors: A. Kutup, Z.-Z. Lin, and B. Radosevic-Stasic

Copyright © 2013 Ashwani Rajput et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Markowitz and M. M. Bertagnolli, “Molecular basis of colorectal cancer,” The New England Journal of Medicine, vol. 361, no. 25, pp. 2404–2460, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. X. Nguyen, P. D. Bos, and J. Massague, “Metastasis: from dissemination to organ-specific colonization,” Nature Reviews Cancer, vol. 9, no. 4, pp. 274–284, 2009. View at Publisher · View at Google Scholar
  3. P. D. Bos, D. X. Nguyen, and J. Massague, “Modeling metastasis in the mouse,” Current Opinion in Pharmacology, vol. 10, no. 5, pp. 571–577, 2010. View at Google Scholar
  4. G. P. Gupta and J. Massagué, “Cancer metastasis: building a framework,” Cell, vol. 127, no. 4, pp. 679–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. X. H. F. Zhang, Q. Wang, W. Gerald et al., “Latent bone metastasis in breast cancer tied to Src-dependent survival signals,” Cancer Cell, vol. 16, no. 1, pp. 67–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Talmadge, R. K. Singh, I. J. Fidler, and A. Raz, “Murine models to evaluate novel and conventional therapeutic strategies for cancer,” American Journal of Pathology, vol. 170, no. 3, pp. 793–804, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. C. M. Ghajar and M. J. Bissell, “Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging,” Histochemistry and Cell Biology, vol. 130, no. 6, pp. 1105–1118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. B. Menon, N. Ronkina, J. Schwermann, A. Kotlyarov, and M. Gaestel, “Fluorescence-based quantitative scratch wound healing assay demonstrating the role of MAPKAPK-2/3 in fibroblast migration,” Cell Motility and the Cytoskeleton, vol. 66, no. 12, pp. 1041–1047, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Bernards and R. A. Weinberg, “A progression puzzle,” Nature, vol. 418, no. 6900, article 823, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. I. J. Fidler, “The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited,” Nature Reviews Cancer, vol. 3, no. 6, pp. 453–458, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. K. Frese and D. A. Tuveson, “Maximizing mouse cancer models,” Nature Reviews Cancer, vol. 7, no. 9, pp. 645–658, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Jonkers and A. Berns, “Conditional mouse models of sporadic cancer,” Nature Reviews Cancer, vol. 2, no. 4, pp. 251–265, 2002. View at Google Scholar · View at Scopus
  13. C. A. Klein, “Parallel progression of primary tumours and metastases,” Nature Reviews Cancer, vol. 9, no. 4, pp. 302–312, 2009. View at Google Scholar
  14. J. J. Yin, K. Selander, J. M. Chirgwin et al., “TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development,” Journal of Clinical Investigation, vol. 103, no. 2, pp. 197–206, 1999. View at Google Scholar · View at Scopus
  15. S. Chowdhury, G. M. Howell, A. Rajput et al., “Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer,” PLoS One, vol. 6, no. 5, Article ID e19335, 2011. View at Publisher · View at Google Scholar
  16. Y. P. Hu, S. B. Patil, M. Panasiewicz et al., “Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor,” Cancer Research, vol. 68, no. 19, pp. 8004–8013, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Ongchin, E. Sharratt, I. Dominguez et al., “The effects of epidermal growth factor receptor activation and attenuation of the TGFβ pathway in an orthotopic model of colon cancer,” Journal of Surgical Research, vol. 156, no. 2, pp. 250–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Rajput, I. D. San Martin, R. Rose et al., “Characterization of HCT116 human colon cancer cells in an orthotopic model,” Journal of Surgical Research, vol. 147, no. 2, pp. 276–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. The Cancer Genome Atlas Network, “Comprehensive molecular characterization of human colon and rectal cancer,” Nature, vol. 487, no. 7407, pp. 330–337, 2012. View at Google Scholar
  20. M. G. Brattain, A. E. Levine, S. Chakrabarty, L. C. Yeoman, J. K. V. Willson, and B. Long, “Heterogeneity of human colon carcinoma,” Cancer and Metastasis Review, vol. 3, no. 3, pp. 177–191, 1984. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Chowdhury, G. M. Howell, C. A. Teggart et al., “Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor β (TGFβ) receptor II leading to cancer cell death,” The Journal of Biological Chemistry, vol. 286, no. 35, pp. 30937–30948, 2011. View at Publisher · View at Google Scholar
  22. A. Rajput, A. P. Koterba, J. L. Kreisberg, J. M. Foster, J. K. V. Willson, and M. G. Brattain, “A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo,” Cancer Research, vol. 67, no. 2, pp. 665–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Simms, A. Rajput, E. A. Sharratt et al., “Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells,” BMC Cancer, vol. 12, no. 1, article 221, 2012. View at Publisher · View at Google Scholar
  24. G. Francia, W. Cruz-Munoz, S. Man, P. Xu, and R. S. Kerbel, “Mouse models of advanced spontaneous metastasis for experimental therapeutics,” Nature Reviews Cancer, vol. 11, no. 2, pp. 135–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Furukawa, T. Kubota, M. Watanabe et al., “A suitable model for experimental liver metastasis of human colon cancer xenografts using mice with severe combined immunodeficiency,” Journal of Surgical Oncology, vol. 52, no. 1, pp. 64–67, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Morikawa, S. M. Walker, J. M. Jessup, and I. J. Fidler, “In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice,” Cancer Research, vol. 48, no. 7, pp. 1943–1948, 1988. View at Google Scholar · View at Scopus
  27. C. Wilmanns, D. Fan, C. A. O'Brian, C. D. Bucana, and I. J. Fidler, “Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil,” International Journal of Cancer, vol. 52, no. 1, pp. 98–104, 1992. View at Google Scholar · View at Scopus
  28. W. Cruz-Munoz, S. Man, P. Xu, and R. S. Kerbel, “Development of a preclinical model of spontaneous human melanoma central nervous system metastasis,” Cancer Research, vol. 68, no. 12, pp. 4500–4505, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. J. Fidler and I. R. Hart, “Biological diversity in metastatic neoplasms: origins and implications,” Science, vol. 217, no. 4564, pp. 998–1003, 1982. View at Google Scholar · View at Scopus
  30. G. Francia, U. Emmenegger, C. R. Lee et al., “Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using β-human choriogonadotropin secreting tumor cell lines,” Molecular Cancer Therapeutics, vol. 7, no. 10, pp. 3452–3459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Munoz, S. Man, Y. Shaked et al., “Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy,” Cancer Research, vol. 66, no. 7, pp. 3386–3391, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Lu, J. Kitaura, T. Oki et al., “Identification of TSC-22 as a potential tumor suppressor that is upregulated by Flt3-D835V but not Flt3-ITD,” Leukemia, vol. 21, no. 11, pp. 2246–2257, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Nakamura, J. Kitaura, Y. Enomoto et al., “Transforming growth factor-β-stimulated clone-22 is a negative-feedback regulator of Ras/Raf signaling: implications for tumorigenesis,” Cancer Science, vol. 103, no. 1, pp. 26–33, 2012. View at Publisher · View at Google Scholar
  34. A. Berndt, C. L. Cario, K. A. Silva et al., “Identification of Fat4 and Tsc22d1 as novel candidate genes for spontaneous pulmonary adenomas,” Cancer Research, vol. 71, no. 17, pp. 5779–5791, 2012. View at Publisher · View at Google Scholar
  35. C. M. Khoury, Z. Yang, X. Y. Li, M. Vignali, S. Fields, and M. T. Greenwood, “A TSC22-like motif defines a novel antiapoptotic protein family,” FEMS Yeast Research, vol. 8, no. 4, pp. 540–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Barretina, G. Caponigro, N. Stransky et al., “The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity,” Nature, vol. 483, no. 7391, pp. 603–607, 2012. View at Publisher · View at Google Scholar
  37. S. Chowdhury, S. Ammanamanchi, and G. M. Howell, “Epigenetic targeting of transforming growth factor β receptor II and implications for cancer therapy,” Molecular and Cellular Pharmacology, vol. 1, no. 1, pp. 57–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Ciriello, E. Cerami, C. Sander, and N. Schultz, “Mutual exclusivity analysis identifies oncogenic network modules,” Genome Research, vol. 22, no. 2, pp. 398–406, 2012. View at Publisher · View at Google Scholar